Loading…
111, Inc. is projected to rise to $3.93 by 2027, a +9% move from its current price of $3.62. YI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.46 | $3.62 | $3.78 | -0.02% |
| Aug 6 | $3.40 | $3.62 | $3.85 | -0.03% |
| Aug 7 | $3.35 | $3.62 | $3.90 | -0.05% |
| Aug 8 | $3.31 | $3.61 | $3.95 | -0.07% |
| Aug 9 | $3.27 | $3.61 | $3.99 | -0.08% |
| Aug 10 | $3.24 | $3.61 | $4.03 | -0.10% |
| Aug 11 | $3.21 | $3.61 | $4.06 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.21 | $3.61 | $4.06 | -0.11% |
| Week 2 | $3.06 | $3.61 | $4.26 | -0.23% |
| Week 3 | $2.94 | $3.60 | $4.42 | -0.34% |
| Week 4 | $2.85 | $3.60 | $4.56 | -0.45% |
| Week 5 | $2.76 | $3.60 | $4.68 | -0.57% |
| Week 6 | $2.69 | $3.59 | $4.79 | -0.68% |
| Week 7 | $2.63 | $3.59 | $4.90 | -0.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People’s Republic of China. It operates through two segments, B2C and B2B. 111, Inc.
offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements and medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies’ historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services.
Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers.
The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People’s Republic of China.
111, Inc. is a healthcare company based in China, identified by the symbol YI and categorized in Healthcare. Its current price is $3.85 with a market capitalization of $33.87M and it holds a rank of 4437.
The near‑term price picture is framed by a neutral outlook with a gradual, long‑term path toward higher prices according to the provided year‑by‑year forecast.
In 2026 the forecast shows an average price of $3.85, moving through 2027 at an average of $4.17 and modestly fluctuating in the following years before a bullish shift appears in 2032. By 2032 the average price is projected to $5.55 with a 44.1% ROI, continuing through 2033 ($5.41; 40.4% ROI) and 2034 ($4.91; 27.6% ROI). Long‑range projections indicate substantial upside, with the 2040 average priced at $7.69 and a 99.8% ROI, and the 2050 average at $12.29 with a 219.2% ROI.
These figures imply a meaningful multi‑year rebound after a flatter near term.
A major floor 14.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 21.9% above — a clean break opens room to run.
A major ceiling 93.3% above — clearing it would confirm fresh momentum.
Key YI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of YI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.79 | Sell | $3.81 | Sell |
| MA 10 | $3.80 | Sell | $3.82 | Sell |
| MA 20 | $3.88 | Sell | $3.91 | Sell |
| MA 50 | $4.38 | Sell | $4.40 | Sell |
| MA 100 | $5.39 | Sell | $4.94 | Sell |
| MA 200 | $5.19 | Sell | $5.26 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.99 | Neutral |
| Stoch RSI (14) | 94.16 | Sell |
| CCI (20) | -13.75 | Neutral |
| Williams %R (14) | -30.95 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | -0.52 | Sell |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 69.05 | Neutral |
| TRIX (15) | -0.70 | Sell |
| Awesome (5,34) | -0.24 | Sell |
| Ultimate (7,14,28) | 52.16 | Neutral |
| Momentum (10) | 0.22 | Buy |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 3.77 | Sell |
| ADX (14) | 18.07 | Neutral |
| ATR (14) | 0.16 | Info |
The 30‑day technical picture is NEUTRAL, with RSI14 at 50. The current move is bounded by near‑term support and resistance, with a defined support at $3.56 and a resistance at $4.41. The 30‑day price range spans from a low of $2.85 to a high of $5.21.
Moving averages suggest a cautious near‑term balance, with SMA50 at $4.42 and SMA200 at $5.19. The stock’s volatility remains elevated, reflecting an annualized volatility of 90%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.76 | $3.62 | $4.76 | 0% | Neutral | |
| $2.96 | $3.93 | $5.61 | +9% | Neutral | |
| $2.59 | $3.61 | $5.46 | 0% | Neutral | |
| $2.50 | $3.64 | $5.75 | +1% | Neutral | |
| $2.24 | $3.38 | $5.53 | -7% | Neutral | |
| $2.30 | $3.59 | $6.06 | -1% | Neutral | |
| $3.24 | $5.24 | $9.08 | +45% | Bullish | |
| $3.09 | $5.14 | $9.14 | +42% | Bullish | |
| $2.71 | $4.65 | $8.44 | +28% | Bullish | |
| $2.89 | $5.11 | $9.48 | +41% | Bullish | |
| $3.59 | $7.27 | $14.68 | +101% | Bullish | |
| $5.29 | $11.76 | $26.82 | +225% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.76 | $3.62 | $4.62 | +0.00% |
| September 2026 | $3.14 | $3.78 | $4.72 | +4.41% |
| October 2026 | $2.93 | $3.56 | $4.53 | -5.63% |
| November 2026 | $2.88 | $3.54 | $4.57 | -0.58% |
| December 2026 | $2.94 | $3.65 | $4.76 | +2.92% |
Click any year to see its month-by-month YI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, YI could reach as high as $4.76, with a base case around $3.62 and support toward $2.76 — roughly 0% from $3.62. A consolidation phase looks the most probable path here.
Expect YI to range from $2.96 to $5.61 through 2027. The $3.93 average target implies a +9% move from current prices. That is up +9% on the projected 2026 average. Price action looks broadly range-bound.
The YI price prediction for 2028 points to an average of $3.61 (low $2.59, high $5.46) — a potential decline of 0% on today's $3.62. A consolidation phase looks the most probable path here.
In 2029, YI is projected to trade between $2.50 and $5.75, averaging $3.64 — a potential gain of +1% from today's $3.62. That is up +1% on the projected 2028 average. Price action looks broadly range-bound.
111, Inc.'s 2030 outlook centres on $3.38, within a $2.24 to $5.53 range. That is -7% versus the projected 2029 average. That marks a -7% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, YI could reach as high as $6.06, with a base case around $3.59 and support toward $2.30 — roughly -1% from $3.62. Price action looks broadly range-bound.
Expect YI to range from $3.24 to $9.08 through 2032. The $5.24 average target implies a +45% move from current prices. That is up +46% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The YI price prediction for 2033 points to an average of $5.14 (low $3.09, high $9.14) — a potential gain of +42% on today's $3.62. Momentum favours further upside here.
In 2034, YI is projected to trade between $2.71 and $8.44, averaging $4.65 — a potential gain of +28% from today's $3.62. That is -10% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
111, Inc.'s 2035 outlook centres on $5.11, within a $2.89 to $9.48 range. That is up +10% on the projected 2034 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2040, YI could reach as high as $14.68, with a base case around $7.27 and support toward $3.59 — roughly +101% from $3.62. Buyers look set to stay in control over this stretch.
Expect YI to range from $5.29 to $26.82 through 2050. The $11.76 average target implies a +225% move from current prices. That is up +62% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in YI today (≈ 276.472215 YI) could be worth
$3,252.59
+$2,252.59 (+225%) by 2050 · US Dollar
Based on the average projected YI price of $11.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in YIwould be worth at today's price.
$1,000 invested in YI on Jul 31, 2025 (≈ 145.56041 YI) would be worth
$526.49
-$473.51 (-47.4%) today · 0.53× · US Dollar
Based on a YI entry price of $6.87 vs. today's $3.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.8 | $951.84 | -4.8% |
| 1 month ago | $4.14 | $873.67 | -12.6% |
| 3 months ago | $6 | $602.83 | -39.7% |
| 6 months ago | $7.4 | $488.78 | -51.1% |
| 1 year ago | $6.87 | $526.49 | -47.4% |
| All time (5.0y) ago | $6.33 | $571.41 | -42.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our YI forecast.
Our base-case forecast reaches $7.20 around 2040.
Implied market cap at $7.20: $37.42M
The multi‑year forecast shows a shift to a bullish trajectory starting in 2032, with the average price rising from $5.55 in 2032 to higher levels through 2035 ($5.39) and beyond. The 2032 forecast carries a 44.1% ROI, followed by 2033 at 40.4% ROI and 2034 at 27.6% ROI, signaling a sustained upward path through mid‑decade. By 2040, the average price is projected to $7.69 with a 99.8% ROI, and by 2050 the average is $12.29 with a 219.2% ROI.
These long‑horizon projections depict meaningful upside potential, punctuated by notable gains in the 2040s and beyond. However, there are mixed outcomes in the near term (e.g., 2026–2029 hover around the low‑to‑mid $3s to $4s, with some years showing small negative ROIs). Overall, the forecast emphasizes a substantial long‑term rise with higher‑price targets in 2032–2050, balanced by the inherent uncertainty of future market dynamics.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $2.31, an average of $3.53, and a max of $5.83, with an ROI of -8.3% and neutral sentiment.
Near term is neutral with an average around $3.85 (2026) and $4.17 (2027). The forecast turns bullish in 2032 with an average of $5.55 and a high potential by 2040 (average $7.69, ROI 99.8%) and 2050 (average $12.29, ROI 219.2%), but several years show flat or negative ROIs. These are estimates and not guarantees.
Yes, the forecast shows potential to exceed $10: the 2035 average is $5.39 with a max of $10.13, the 2040 max is $15.75, and the 2050 max is $28.26.
Current price is $3.85 and market cap is $33.87M.
The 30‑day range is $2.85 to $5.21.
111, Inc. Community Discussion
0Share your 111, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.